Pressure BioSciences Announces First Manufacturing Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions
Low or widely varying levels of hemp-derived cannabinoid absorption and biological accessibility is a crucial concern that may substantially impact the bioavailability and efficiency of the potential benefits of hemp-derived cannabinoid products on the market today.
The Business formerly announced plans for its first manufacturing run of twelve (12) BaroShear K45 processing systems with estimated completion times throughout the 4th quarter of2020 Due to inefficiencies triggered by the COVID-19 pandemic, the Business now thinks that all 12 systems will be completed in time for shipment and setup to occur during the very first quarter of2021
Mr. Kenneth F. Micciche, Director of PBI’s UST Program, said: “The order for the last offered BaroShear K45 system from our preliminary production run was received from an interesting young company out of Massachusetts called Canopy CBD Farms, LLC. The senior management of Canopy CBD Farms is comprised of really experienced and skilled entrepreneurs and magnate. They have actually already garnered the trust and commitment of many companies in or going into in the commercial industrial hemp area. They utilize only the highest quality hemp biomass offered and the latest processing innovations to meet or exceed market requirements. We are very happy to have them as a client.”
Mr. John Westlake, Creator and President of Canopy CBD Farms, LLC., commented: “Scientific information strongly supports the vital understanding that hemp-derived cannabinoid oil needs to be processed into a successfully water-soluble, long-lasting steady nanoemulsion to achieve the greatest quality hemp-derived cannabinoid products possible.
Mr. Richard T. Schumacher, President and CEO of PBI, commented: “We are very gratified and ecstatic that the preliminary production run of our BaroShear K45 processing systems has offered out.
Mr. Schumacher continued: “Much progress has actually been made in the development of this really novel and innovative nanoemulsification processing system. Upon their approval, we expect to deliver and install all 12 BaroShear K45 systems during Q1 2021, at which point we will acknowledge roughly $ 2.4 million in income.
About Canopy CBD Farms, LLC.
Canopy CBD Farms is a state certified Massachusetts hemp processor and manufacturing company.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the advancement and sale of ingenious, broadly enabling, pressure-based options for the worldwide life sciences and other markets. In addition, major brand-new market opportunities have emerged in the usage of our pressure-based innovations in the following areas: (1) the usage of our just recently gotten, trademarked technology from BaroFold, Inc. (the “BaroFold” technology) to enable entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Innovation (” UST”) platform to (i) produce steady nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or space temperature level steady low-acid liquid foods that can not be effectively maintained using existing non-thermal innovations.
Forward Looking Declarations
This press release consists of forward-looking declarations. These dangers, unpredictabilities, and other factors include, but are not restricted to, the risks and unpredictabilities gone over under the heading “Danger Factors” in the Business’s Yearly Report on Form 10- K for the year ended December 31, 2018, and other reports submitted by the Business from time to time with the SEC.
For additional information about PBI and this press release, please click on the following site link:
Please visit us on Facebook, LinkedIn, and Twitter.
Richard T. Schumacher, President and CEO
Kenneth F. Micciche, Director– UST Program
SOURCE Pressure BioSciences, Inc.